92 Recruiting Studies Using Abemaciclib
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Abemaciclib
Abemaciclib Neuropharmacokinetics of Diffuse Midline Glioma Using Intratumoral Microdialysis
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Glioma
View Study & Checklist ➔A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
Prostate Cancer
View Study & Checklist ➔SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma
📍 University of Colorado Cancer Center, Anschutz Medical Campus — Aurora, Colorado
Advanced Dedifferentiated Liposarcoma
View Study & Checklist ➔Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
📍 Research Site — Tucson, Arizona
Locally Advanced (Inoperable) or Metastatic Breast Cancer
View Study & Checklist ➔Abemaciclib (LY2835219) Plus Fulvestrant Compared to Placebo Plus Fulvestrant in Previously Treated Breast Cancer
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
Breast Neoplasm
View Study & Checklist ➔Genetic Testing in Guiding Treatment for Patients With Brain Metastases
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
CDK Gene Mutation
View Study & Checklist ➔Osimertinib and Abemaciclib in EGFR Mutant Non-Small Cell Lung Cancer After Osimertinib Resistance
📍 UCSD Moores Cancer Center — La Jolla, California
Lung Cancer
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
📍 Highlands Oncology Group - Duplicate 2 — Springdale, Arkansas
Non Small Cell Lung Cancer
View Study & Checklist ➔An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
📍 Research Site — Dothan, Alabama
Breast Cancer, Early Breast Cancer
View Study & Checklist ➔A Real-life Study to Understand the Use and Effects of Palbociclib in US Patients With Breast Cancer
📍 Pfizer New York — New York, New York
Breast Cancer
View Study & Checklist ➔A Study of Abemaciclib in Recurrent Glioblastoma
📍 University of California Los Angeles — Los Angeles, California
Glioblastoma
View Study & Checklist ➔Abemaciclib (LY2835219) in Patients With Recurrent Primary Brain Tumors
📍 Hartford Healthcare Cancer Institute @ Hartford Hospital (Data collection only) — Hartford, Connecticut
Brain Tumor
View Study & Checklist ➔Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
📍 Dothan Hematology and Oncology — Dothan, Alabama
Breast Cancer
View Study & Checklist ➔Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
📍 University of Colorado — Denver, Colorado
Advanced Digestive System Neuroendocrine Neoplasm
View Study & Checklist ➔Abemaciclib and Letrozole to Treat Endometrial Cancer
📍 University of South Alabama Mitchell Cancer Center — Mobile, Alabama
Endometrial Cancer
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
📍 The University of Arizona Cancer Center — Tucson, Arizona
Metastatic Breast Cancer
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)
📍 Arizona Oncology Associates, P.C. - HOPE — Prescott, Arizona
Prostatic Neoplasms
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors
📍 UCSF Helen Diller Family CCC — San Francisco, California
Ovarian Cancer
View Study & Checklist ➔Study of Abemaciclib in Dedifferentiated Liposarcoma
📍 Memorial Sloan Kettering Cancer Center — New York, New York
Sarcoma
View Study & Checklist ➔Abemaciclib in Patients with Oligodendroglioma
📍 University of Pennsylvania — Philadelphia, Pennsylvania
Oligodendroglioma, Adult
View Study & Checklist ➔Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer
📍 University of Alabama Birmingham — Birmingham, Alabama
Breast Cancer
View Study & Checklist ➔TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer
📍 Stamford Hospital — Stamford, Connecticut
Breast Cancer
View Study & Checklist ➔A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy
📍 Children's Hospital of Orange County - Orange — Orange, California
Glioma
View Study & Checklist ➔(CLONEVO): Cell cycLe inhbitiON to Target the EVolution of UrOthelial Cancer
📍 Weill Cornell Medicine — New York, New York
Bladder Cancer
View Study & Checklist ➔Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
📍 Research Site — Phoenix, Arizona
ER-Positive HER2-Negative Breast Cancer
View Study & Checklist ➔Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma
📍 University of Texas MD Anderson Cancer Center — Houston, Texas
Malignant Neoplasms of Female Genital Organs
View Study & Checklist ➔CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
📍 Phoenix Children's Hospital — Phoenix, Arizona
Sarcoma, Ewing
View Study & Checklist ➔A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Breast Cancer
View Study & Checklist ➔LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer
📍 M D Anderson Cancer Center — Houston, Texas
Metastatic Colon Adenocarcinoma
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer
📍 St. Bernards Medical Center — Jonesboro, Arkansas
Breast Neoplasms
View Study & Checklist ➔TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)
📍 Stanford Women's Cancer Center — Palo Alto, California
Breast Cancer
View Study & Checklist ➔Abemaciclib Plus Ramucirumab for Esophageal/Gastroesophageal Junction Ca
📍 Baylor University Medical Center, Charles A Sammons Cancer Center — Dallas, Texas
Metastatic Esophageal Adenocarcinoma
View Study & Checklist ➔Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast Cancer
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Anatomic Stage IV Breast Cancer AJCC v8
View Study & Checklist ➔A Study of Nonsteroidal Aromatase Inhibitors Plus Abemaciclib (LY2835219) in Postmenopausal Women With Breast Cancer
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
Breast Cancer
View Study & Checklist ➔A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
Breast Neoplasms
View Study & Checklist ➔A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
📍 Highlands Oncology Group — Fayetteville, Arkansas
Non Small Cell Lung Cancer
View Study & Checklist ➔Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
📍 The Kirklin Clinic of UAB Hospital — Birmingham, Alabama
Breast Cancer
View Study & Checklist ➔Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
📍 Keck Medicine of USC Koreatown — Los Angeles, California
Anatomic Stage III Breast Cancer AJCC v8
View Study & Checklist ➔Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
📍 UT MD Anderson Cancer Center — Houston, Texas
Advanced Dedifferentiated Liposarcoma
View Study & Checklist ➔Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
📍 Moffitt Cancer Center — Tampa, Florida
Brain Metastases
View Study & Checklist ➔ETHAN - ET for Male BC
📍 Georgetown University Medical Center — Washington D.C., District of Columbia
Male Breast Cancer
View Study & Checklist ➔Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
📍 Siteman Cancer Center at Washington University — St Louis, Missouri
Anatomic Stage III Breast Cancer AJCC v8
View Study & Checklist ➔Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
📍 Florida Cancer Specialists — Orlando, Florida
Breast Cancer
View Study & Checklist ➔Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
📍 Mayo Clinic Scottsdale — Scottsdale, Arizona
Non Small Cell Lung Cancer
View Study & Checklist ➔Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer
📍 Moffitt Cancer Center — Tampa, Florida
Metastatic Breast Cancer
View Study & Checklist ➔RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Endometrial Cancer
View Study & Checklist ➔A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors
📍 Mayo Clinic of Scottsdale — Scottsdale, Arizona
Breast Cancer
View Study & Checklist ➔A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Anatomic Stage IV Breast Cancer AJCC v8
View Study & Checklist ➔Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.
📍 City of Hope Medical Center — Duarte, California
Anatomic Stage IV Breast Cancer AJCC v8
View Study & Checklist ➔Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Recurrent Endometrial Carcinoma
View Study & Checklist ➔Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
📍 Parkland Hospital — Dallas, Texas
Breast Cancer
View Study & Checklist ➔A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
📍 Johns Hopkins University (Data Collection Only) — Baltimore, Maryland
Metastatic Renal Cell Carcinoma
View Study & Checklist ➔Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
📍 Providence Medical Foundation — Fullerton, California
Breast Neoplasms
View Study & Checklist ➔VS-6766+Abema+Fulv in Met HR+/HER- BC
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Breast Cancer
View Study & Checklist ➔A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors
📍 Research Site — St Louis, Missouri
ER+ HER2- Advanced Breast Cancer
View Study & Checklist ➔Abemaciclib in Patients With HIV-associated and HIV-negative Kaposi Sarcoma
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Kaposi Sarcoma
View Study & Checklist ➔A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Endometrial Cancer
View Study & Checklist ➔Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
📍 University of California, San Francisco — San Francisco, California
Castration-Resistant Prostate Carcinoma
View Study & Checklist ➔Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Cancer
View Study & Checklist ➔RADIANT: Pre-op Radiation With Abemaciclib and Letrozole
📍 RWJBarnabas Health Clara Maas Medical Center — Belleville, New Jersey
Breast Cancer
View Study & Checklist ➔A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
📍 University of Arizona Cancer Center — Tucson, Arizona
Breast Cancer
View Study & Checklist ➔Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Anatomic Stage I Breast Cancer AJCC v8
View Study & Checklist ➔First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
📍 Ellison Clinic at Saint John's — Los Angeles, California
Breast Cancer
View Study & Checklist ➔A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
📍 Childrens Hospital of Alabama — Birmingham, Alabama
Neoplasms
View Study & Checklist ➔Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
📍 University of Illinois — Chicago, Illinois
Breast Cancer
View Study & Checklist ➔Phase 1/2 Study to Evaluate EP0062 as Monotherapy and in Combination in Patients With Advanced or Metastatic AR+/HER-2-/ER+ Breast Cancer
📍 Yale School of Medicine — New Haven, Connecticut
Hormone Receptor-positive Breast Cancer
View Study & Checklist ➔A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
📍 Alaska Oncology and Hematology — Anchorage, Alaska
Breast Neoplasms
View Study & Checklist ➔Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration
📍 Mayo Clinic — Jacksonville, Florida
Chondrosarcoma
View Study & Checklist ➔Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
📍 Chao Family Comprehensive Cancer Center, University of California, Irvine — Orange, California
Breast Cancer
View Study & Checklist ➔Cyclin-Dependent Kinase (CDK)4/6 Inhibitor Abemaciclib for Neurofibromatosis Type I (NF1) Related Atypical Neurofibromas
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Neurofibromatosis 1
View Study & Checklist ➔Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
📍 UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California
Metastatic Microsatellite Stable Colorectal Carcinoma
View Study & Checklist ➔CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
📍 Dana Farber Cancer Institute — Boston, Massachusetts
Adenoid Cystic Carcinoma
View Study & Checklist ➔BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
📍 Alabama Oncology Princeton — Birmingham, Alabama
HR+/HER2- Breast Cancer
View Study & Checklist ➔INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
📍 University of Alabama at Birmingham — Birmingham, Alabama
Glioblastoma
View Study & Checklist ➔Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Recurrent Ovarian High Grade Serous Adenocarcinoma
View Study & Checklist ➔Study of AVZO-021 in Patients With Advanced Solid Tumors
📍 Yale Cancer Center — New Haven, Connecticut
Advanced Solid Tumor
View Study & Checklist ➔Abemaciclib in Newly Diagnosed Meningioma Patients
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
Meningioma
View Study & Checklist ➔A Phase 1 Study of Neoadjuvant Abemaciclib in Combination With Radiation Therapy for Liposarcomas
📍 Fred Hutch/University of Washington Cancer Consortium — Seattle, Washington
Retroperitoneal Sarcoma
View Study & Checklist ➔ALPINE: Maintenance Letrozole/Abemaciclib
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
Endometrial Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
📍 City of Hope — Duarte, California
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
View Study & Checklist ➔ABemacicliB or Abemaciclib and HydroxYchloroquine to Target Minimal Residual Disease in Breast Cancer
📍 Abramson Cancer Center of the University of Pennsylvania — Philadelphia, Pennsylvania
Breast Cancer
View Study & Checklist ➔A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
Myelofibrosis Due to and Following Polycythemia Vera
View Study & Checklist ➔Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Intracranial Meningioma
View Study & Checklist ➔Using Tumor Models to Determine Treatments
📍 Princess Margaret Cancer Centre — Toronto, Ontario
Pancreatic Ductal Carcinoma
View Study & Checklist ➔A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
📍 Memorial Sloan Kettering at Basking Ridge (All protocol activities) — Basking Ridge, New Jersey
Metastatic Breast Cancer
View Study & Checklist ➔A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
📍 City of Hope — Duarte, California
Metastatic Breast Cancer
View Study & Checklist ➔A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
📍 Southern Cancer Center — Daphne, Alabama
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
View Study & Checklist ➔TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
📍 University of Alabama at Birmingham Comprehensive Cancer Center — Birmingham, Alabama
Lymphoma, Non-Hodgkin
View Study & Checklist ➔A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial Cancer
📍 Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
Endometrial Cancer
View Study & Checklist ➔Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
📍 Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
Advanced Breast Cancer
View Study & Checklist ➔Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast Cancer
📍 Mount Sinai Beth Israel — New York, New York
Breast Cancer
View Study & Checklist ➔Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer
📍 Research Site — Gilbert, Arizona
Advanced Breast Cancer
View Study & Checklist ➔